$34.620
-0.454 (-1.31%)收盘时
AMN 资讯
AMN 事件
AMN Healthcare Sees Q3 Revenue of $640M-$655M
AMN Healthcare sees Q3 revenue $640M-$655M, consensus $618.25M
AMN Healthcare Reports Q2 Revenue of $673M, Beating Expectations
Reports Q2 revenue $673M, consensus $628.36M. "We are very pleased with how the AMN team executed for our healthcare professionals and clients in the second quarter," said Cary Grace, President and Chief Executive Officer of AMN Healthcare. "Our strong performance produced year-over-year revenue growth in our travel nurse, international nurse, allied, schools, and search solutions. We continue to deepen our relationships with our clients, as reflected in our solid MSP and search revenue growth. Overall demand growth improved through the quarter, and the trend improved in July, giving us momentum that is reflected in third quarter guidance."
AMN Healthcare Appoints New Executives
AMN Healthcare announced the appointments of Kristy Willis as Chief Commercial Officer and Holly Novak as Chief People Officer, both effective June 15. In these roles, Willis and Novak will strengthen the company's executive leadership team as it advances its next phase of growth, innovation, and organizational alignment.
AMN Healthcare Reports Q1 Revenue of $1.378B
Reports Q1 revenue $1.378B, consensus $1.23B. "Our first quarter performance demonstrated strong execution across AMN, with results exceeding our expectations and guidance while navigating a dynamic market environment," said Cary Grace, President and Chief Executive Officer of AMN Healthcare. "We delivered solid underlying growth in Nurse and Allied Solutions, saw momentum return in international staffing and search, and continued to advance our technology-enabled workforce solutions. The AMN team did an outstanding job supporting our clients and healthcare professionals, demonstrating the power of our enhanced technology platform and solutions to deliver at our highest level since the pandemic."
Company Expects Q2 2026 Adjusted EBITDA Margin of 6.7%-7.2%
Sees Q2 adjusted EBITDA margin 6.7%-7.2%. "Revenue in the second quarter of 2026 is expected to be 4-6% lower than the prior year, or down 3-5% excluding labor disruption revenue of approximately $10 million this quarter compared with $16 million in the second quarter of 2025. Nurse and Allied Solutions segment revenue is expected to be down 0-2% year over year. Physician and Leadership Solutions segment revenue is expected to be down 6-8% year over year. Technology and Workforce Solutions segment revenue is projected to be down 14-16% year over year, including a (4%) effect from the divestiture of Smart Square at the beginning of third quarter 2025," the company stated.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。